Published in Sci Rep on August 16, 2016
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
Antibiotic resistance-the need for global solutions. Lancet Infect Dis (2013) 15.01
Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta (1999) 4.71
Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta (1999) 3.49
Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother (2000) 3.06
Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis (2005) 2.41
Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev (2004) 2.08
Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother (2006) 1.87
MRSA virulence and spread. Cell Microbiol (2012) 1.79
Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol (2000) 1.74
Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol (2013) 1.73
Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta (2008) 1.66
AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int (2008) 1.54
Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers (2008) 1.51
Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J Biol Chem (2005) 1.40
Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. J Am Chem Soc (2007) 1.40
Alpha-helical antimicrobial peptides--using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta (2006) 1.37
Alternatives to antibiotics-a pipeline portfolio review. Lancet Infect Dis (2016) 1.37
Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther (2006) 1.23
Tryptophan fluorescence study of the interaction of penetratin peptides with model membranes. Eur J Biochem (2002) 1.15
The melanocortin system in control of inflammation. ScientificWorldJournal (2010) 1.14
Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions. J Biol Chem (2012) 1.14
Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. Biochim Biophys Acta (2010) 1.13
Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol (1998) 1.08
alpha-Melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev (1993) 1.04
The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. Am J Pathol (2011) 1.03
alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis (2007) 1.00
Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides. Biochemistry (2010) 0.97
Characterization of the structure and membrane interaction of the antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs. Biophys J (2007) 0.94
Mechanism of action of puroindoline derived tryptophan-rich antimicrobial peptides. Biochim Biophys Acta (2013) 0.94
Comparing bacterial membrane interactions of antimicrobial peptides and their mimics. Methods Mol Biol (2010) 0.94
α-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation. J Invest Dermatol (2012) 0.93
In vitro antimicrobial activity of alpha-melanocyte stimulating hormone against major human pathogen Staphylococcus aureus. Peptides (2009) 0.92
C-terminal amino acids of alpha-melanocyte-stimulating hormone are requisite for its antibacterial activity against Staphylococcus aureus. Antimicrob Agents Chemother (2011) 0.88
Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action. FEBS J (2006) 0.88
Antimicrobial properties of alpha-MSH and related synthetic melanocortins. ScientificWorldJournal (2006) 0.88
Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PLoS One (2015) 0.87
Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides. Antimicrob Agents Chemother (2015) 0.87
The effect of charge increase on the specificity and activity of a short antimicrobial peptide. Peptides (2001) 0.86
Alpha-melanocyte-stimulating hormone in normal human physiology and disease states. Trends Endocrinol Metab (2000) 0.86
Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore. Adv Exp Med Biol (2010) 0.86
Mechanisms of resistance to antimicrobial peptides in staphylococci. Biochim Biophys Acta (2015) 0.85
Estimation of average depth of penetration of melanotropins in dimyristoylphosphatidylglycerol vesicles. Biophys Chem (1996) 0.84
Characterization of cell membrane parameters of clinical isolates of Staphylococcus aureus with varied susceptibility to alpha-melanocyte stimulating hormone. Peptides (2012) 0.83
Melanocyte stimulating hormone peptides inhibit TNF-alpha signaling in human dermal fibroblast cells. Peptides (2005) 0.83
Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells. Biochim Biophys Acta (2011) 0.83
Antimicrobial peptides. Curr Biol (2016) 0.81
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. PLoS One (2013) 0.81
Melanotropic peptides-lipid bilayer interaction. Comparison of the hormone alpha-MSH to a biologically more potent analog. Biophys Chem (1997) 0.81
Design and synthesis of melanocortin peptides with candidacidal and anti-TNF-alpha properties. J Med Chem (2005) 0.80
Modeling of alpha-MSH conformations with implicit solvent. J Pept Res (1999) 0.80
Combination of alpha-melanocyte stimulating hormone with conventional antibiotics against methicillin resistant Staphylococcus aureus. PLoS One (2013) 0.80
A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity. Sci Rep (2015) 0.80
Conformational Fine-Tuning of Pore-Forming Peptide Potency and Selectivity. J Am Chem Soc (2015) 0.80
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor. J Med Chem (2015) 0.79
Relationship between peptide structure and antimicrobial activity as studied by de novo designed peptides. Biochim Biophys Acta (2014) 0.77
Importance of residue 13 and the C-terminus for the structure and activity of the antimicrobial peptide aurein 2.2. Biophys J (2010) 0.76
Lipid composition is an important determinant of antimicrobial activity of alpha-melanocyte stimulating hormone. Biophys Chem (2014) 0.76